SharesGrow 7-Criteria Score
All 7 criteria scored · valuation-related highlighted on this page
Appen Limited (APXYY) .
Criteria proven by this page:
- VALUE (0/100, Fail) — the composite valuation score falls below the 60/100 threshold required to pass.
Overall SharesGrow Score: 29/100 with 0/7 criteria passed.
SharesGrow 7-Criteria Score
~
HEALTH
67/100
Debt-to-Equity & liquidity
→ Health
Valuation Snapshot — APXYY
Valuation Multiples
P/E (TTM)0.0
Forward P/EN/A
PEG RatioN/A
Forward PEGN/A
P/B Ratio0.00
P/S Ratio1.27
EV/EBITDA0.0
Per Share Data
EPS (TTM)$-0.04
Book Value / Share$0.00
Revenue / Share$0.44
FCF / Share$0.00
Yields & Fair Value
Earnings YieldN/A
Dividend Yield0.00%
P/E Ratio & Earnings Yield
Earnings Per Share (EPS) History
| Year |
EPS (Diluted) |
Revenue |
Net Income |
Net Margin |
| 2016 |
$0.05 |
$110.94M |
$10.49M |
9.5% |
| 2017 |
$0.07 |
$166.56M |
$11.14M |
6.7% |
| 2018 |
$0.17 |
$364.21M |
$41.73M |
11.5% |
| 2019 |
$0.16 |
$535.49M |
$41.61M |
7.8% |
| 2020 |
$0.19 |
$599.39M |
$38.84M |
6.5% |
| 2021 |
$0.14 |
$595.75M |
$28.52M |
4.8% |
| 2022 |
$-1.24 |
$559.89M |
$-344.86M |
-61.6% |
| 2023 |
$-0.41 |
$411.31M |
$-118.08M |
-28.7% |
| 2024 |
$-0.05 |
$234.29M |
$-20.01M |
-8.5% |
| 2025 |
$-0.04 |
$230.94M |
$-21.83M |
-9.5% |
